Shilpa Medicare has introduced a new hybrid CDMO model that caters to both small and large molecule pharmaceutical companies, including peptide-based therapeutics. The model is designed to provide flexible outsourcing solutions, with oncology as a core area of expertise. In addition
Shilpa Medicare is a Manufacturer/Innovator company operating in the pharmaceutical industry. We are dealing with high-quality Active Pharmaceutical Ingredients (APIs), Formulations, New Drug Delivery Systems and Specialty Chemicals utilising sophisticated technology meticulously in order to comply with international standards/specifications. Today
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
